Moonshot antibodies

DRUG2 trials

Sponsors

Moonshot Antibodies, Centre hospitalier de l'Université de Montréal (CHUM)

Conditions

Soft Tissue Cancer

Phase 1

Clinical Trial to Treat Stage IV Cancer Patients

Enrolling by invitationNCT06674538

Moonshot AntibodiesSoft Tissue Cancer

Start: 2024-12-30End: 2029-01-31Target: 12Updated: 2025-09-22

Phase 1, Open Label Clinical Trial to Treat Stage IV Cancer Patients With Multiple Patient-specific Mutated Cell Surface Proteins With Chimeric Antibodies

Not yet recruitingNCT07783620

Centre hospitalier de l'Université de Montréal (CHUM)Soft Tissue Cancer

Start: 2026-12-01End: 2031-12-01Target: 16Updated: 2026-08-25

Related Papers

Phase 1, open-label clinical trial to treat stage IV cancer patients harboring multiple patient-specific mutated cell surface proteins with chimeric antibodies.

Journal of Clinical Oncology2026-05-28